Search results
5 days ago · The latest Aurinia Pharmaceuticals stock prices, stock quotes, news, and AUPH history to help you invest and trade smarter.
Discover historical prices for AUPH stock on Yahoo Finance. View daily, weekly or monthly format back to when Aurinia Pharmaceuticals Inc. stock was issued.
View Aurinia Pharmaceuticals Inc. AUPH stock quote prices, financial information, real-time forecasts, and company news from CNN.
See the latest Aurinia Pharmaceuticals Inc stock price (AUPH:XNAS), related news, ... Aurinia Pharmaceuticals Inc AUPH. Morningstar Rating Unlock. Stock XNAS Rating as of May 22, 2024. Summary;
Interactive Chart for Aurinia Pharmaceuticals Inc. (AUPH), analyze all the data with a huge range of indicators.
May 14, 2024 · In January 2021, the Company introduced LUPKYNIS ® (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis (LN). The Company’s head office is in Edmonton, Alberta, its U.S. commercial hub is in Rockville, Maryland, and the Company focuses its development efforts globally.
Aurinia Presents Data Reinforcing LUPKYNIS® Safety and Efficacy for People with Lupus Nephritis at Congress of Clinical Rheumatology East 2024. Find the latest Aurinia Pharmaceuticals Inc. (AUPH) stock quote, history, news and other vital information to help you with your stock trading and investing.
